Pancreatic cancer-associated stroma production.

One of the defining features of pancreatic ductal adenocarcinoma (PDAC) is the presence of extensive desmoplasia. The desmoplastic stroma consists of proliferating fibroblasts and pancreatic stellate cells that produce and deposit fibronectin and collagens, inflammatory cells and macrophages that produce chemokines and cytokines, nerve fibers that release nerve growth factors, and marrow-derived stem cells. Stroma production is facilitated by the abundance of growth factors, including fibroblast growth factors (FGFs), epidermal growth factor (EGF) receptor ligands, transforming growth factor-beta (TGF-beta) isoforms, and connective tissue growth factor. Due to its location in the pancreas, stromal cells and pancreatic cancer cells are also exposed to high insulin levels. The stromal compartment stores and synthesizes multiple growth factors and the heparan sulfate proteoglycans glypican-1 and syndecan-1. This unique microenvironment harbors and nourishes the cancer cells, facilitating their invasive and metastatic potential. Targeting the stroma may thus provide novel therapeutic options in this deadly malignancy.

[1]  H. Friess,et al.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. , 1998, The Journal of clinical investigation.

[2]  H. Friess,et al.  Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells , 2002, Molecular carcinogenesis.

[3]  M. Kornmann,et al.  Chemosensitivity testing and test-directed chemotherapy in human pancreatic cancer. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[4]  E. Furth,et al.  Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. , 2006, Cancer research.

[5]  M. Goggins,et al.  Gene Expression Profiling of Tumor–Stromal Interactions between Pancreatic Cancer Cells and Stromal Fibroblasts , 2004, Cancer Research.

[6]  R. Hruban,et al.  Genetic progression in the pancreatic ducts. , 2000, The American journal of pathology.

[7]  M. Korc,et al.  Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines , 2004, Clinical Cancer Research.

[8]  Birgir Gudjonsson,et al.  Cancer of the pancreas: 50 years of surgery , 1987, Cancer.

[9]  R. Hruban,et al.  Molecular pathogenesis of pancreatic cancer. , 2006, Best practice & research. Clinical gastroenterology.

[10]  M. Korc,et al.  Connective tissue growth factor–specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer , 2006, Molecular Cancer Therapeutics.

[11]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[12]  M. Korc,et al.  Growth factor–induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells , 2005, The Journal of cell biology.

[13]  P. Chiao,et al.  Identification of an Autoregulatory Feedback Pathway Involving Interleukin-1α in Induction of Constitutive NF-κB Activation in Pancreatic Cancer Cells* , 2004, Journal of Biological Chemistry.

[14]  T. Greten,et al.  Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis ☆ ☆☆ , 2002 .

[15]  R. DePinho,et al.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.

[16]  M. Miyazaki,et al.  Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow‐derived endothelial cells and myofibroblasts in cancer‐induced stroma , 2005, International journal of cancer.

[17]  P. Guillou,et al.  Biology of pancreatic cancer. , 1991, Gut.

[18]  R. Kuick,et al.  The Molecular Basis of Pancreatic Fibrosis: Common Stromal Gene Expression in Chronic Pancreatitis and Pancreatic Adenocarcinoma , 2004, Pancreas.

[19]  M. Korc,et al.  Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis. , 2002, Molecular cancer therapeutics.

[20]  M. Korc,et al.  Soluble Type II Transforming Growth Factor-β (TGF-β) Receptor Inhibits TGF-β Signaling in COLO-357 Pancreatic Cancer Cells in Vitro and Attenuates Tumor Formation , 2001 .

[21]  H. Hameister,et al.  Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells , 1999, Oncogene.

[22]  A. Buck,et al.  Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. , 2005, Gastroenterology.

[23]  J. Trevino,et al.  c-Src Regulates Constitutive and EGF-mediated VEGF Expression in Pancreatic Tumor Cells Through Activation of Phosphatidyl Inositol-3 Kinase and p38 MAPK , 2005, Pancreas.

[24]  D. Winchester,et al.  Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.

[25]  M. Korc,et al.  Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells , 2004, Clinical Cancer Research.

[26]  W. Nealon,et al.  Inflammatory Mechanisms Contributing to Pancreatic Cancer Development , 2004, Annals of surgery.

[27]  H. Friess,et al.  Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival , 1993 .

[28]  M. Tempero,et al.  AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. , 1999, Gastroenterology.

[29]  G. Adler,et al.  Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. , 2006, Cancer research.

[30]  H. Friess,et al.  Desmoplastic Reaction Influences Pancreatic Cancer Growth Behavior , 2004, World Journal of Surgery.

[31]  H. Friess,et al.  Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.